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Abstract
Red blood cells (RBCs) moving in circulation are continuously exposed to the 
reactive oxygen species (ROS) that are circulating within the vascular system of 
body. The objective of the study is to determine the erythrocyte zeta potential 
and its morphological changes caused by oxidative stress in hypertensive patients 
in relation to the risk of development of cardiovascular disease (myocardial 
infarction). In this retrospective study, we investigated 186 samples, which 
include hypertension patients (n = 64), myocardial infarction patients (n = 52), 
treated myocardial infarction patients (n = 20), and normal healthy volunteers 
(n = 50). Morphological and electrochemical characteristics of RBCs in patients 
were analyzed using scanning electron microscopy and zeta potential study. These 
parameters were also statistically analyzed applying one way ANNOVA (Tukey’s 
comparison) using Graph Pad. Statistical analyses of data showed that Hypertensive 
(ZP-16.06 mV) and cardiac patients (ZP-9.94 mV) RBCs possessed significantly 
reduced zeta potential relative to that of RBCs from healthy individuals (ZP-
23.39 mV) (P-value <0.0001). Microscopic imaging of Hypertensive RBCs revealed 
increased anisocytes and poikilocytes. These parameters were found exacerbated in 
patients suffering from Myocardial infarction. Hence, it can be concluded that ZP 
can be used as an effective diagnostic tool for detection of hypertension associated 
cardiovascular disorder risk.
Keywords: red blood cells (RBCs), zeta potential, erythrocyte fragility,  
lipid peroxidation, hypertension, myocardial infarction
1. Introduction
Hypertension is an emerging public health problem of this millennium and 
it is a major challenge to disclose the mechanism involved in the coexistence of 
hypertension and cardiovascular disease to improve the health of the Hypertensive 
patients. Patients with symptoms of a cardiovascular disease frequently present 
without striking evidence of cardiac specific enzymes in blood laboratory assessments 
or specific electrocardiogram findings. Recently, researchers have reported higher 
mortality risk associated with higher RDW in patient populations with cardiovascular 
disease (CVD) [1]. Nowadays, also there is a growing interest in characterizing 
RBC membrane defects in several diseases, as changes in membrane structure also 
contribute to the pathophysiology of the disease process.
Human erythrocyte contains about 95% of the glutathione which is responsible 
for scavenging reactive oxygen species [2]. Sialic acid is an important factor for 
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maintenance of the surface electrical charge and stability of biological cellular 
system [3]. Erythrocytes and Erythrocyte membrane are more vulnerable to 
peroxidation due to constant exposure to high oxygen tension and richness in 
polyunsaturated fatty acid, respectively [4]. The interaction of Reactive oxygen 
species (ROS) with particularly with fatty acids available in membrane can 
result in undesirable irreversible changes in cellular membrane. The membranes 
are therefore naturally protected by available anti-oxidative enzymes like 
superoxide dismutase, catalase, and glutathione peroxidase and vitamins E and 
A from oxidative damages [5]. By-products of peroxidation have been shown to 
cause profound alterations in the structural organization and functions of the 
cell membrane including decreased membrane fluidity, increased membrane 
permeability, inactivation of membrane-bound enzymes and loss of essential fatty 
acids [6]. Reactive oxygen species are the responsible moiety that are involved 
in the generation and progression of atherosclerosis and that contribute to the 
development of plaque instability in acute MI [7].
Blood viscosity is strongly affected by the surface charge of RBCs and is 
responsible for the spacing between them. A higher surface charge causes 
repulsive forces to increases distant RBCs, preventing their close aggregation, 
lowers the viscosity, and results into very low peripheral resistance to flow. 
Therefore, it can be hypothesized that stress like condition develops in 
hypertension generate ROS which can induce membrane deformity and as 
a result affect the membrane surface charge. The occlusive arterial disease 
resulting from RBC aggregation may develop due to comparable membrane 
deformity [8]. Besides vascular and cardiac tissue integrity, blood and especially 
the RBC, is critical to performing this critical assignment of CV risk assessment 
considering it makes up over 90% of formed elements within blood. In 
cardiovascular diseases, impaired blood rheology has been observed. A direct 
relationship has been found between increased RBC deformability and increased 
risk for arterial hypertension [9]. Accurate risk stratification of patients with 
chronic heart failure is critically important to efficiently target the use of 
evidence-based therapies and identify high-risk patients who may benefit from 
advanced treatments [10].
We tested the hypothesis that variations in zeta potential and deformation of 
erythrocytes were associated with risk of adverse cardiovascular outcomes in a 
population with hypertension that were free of symptomatic heart failure [11]. In 
the present work we envisaged to study and evaluate morphological changes taking 
place in RBCs, erythrocyte fragility, lipid per oxidation and zeta potential which can 
act as invaluable aid in the diagnosis of a hypertension and risk of Cardiovascular 
Disorder in hypertension patients. Hence, the aim of this study was to test the 
hypothesis of association of variation in RBC morphology, erythrocyte fragility 
and zeta potential in hypertension and its relation with the risk of cardiovascular 
disorder in hypertension patients.
2. Morphological characterization
2.1 Preparation of blood Smear
Blood smear was prepared with the aid of wedge method [12]. In this method a 
drop of blood was placed on base closed to one cease of the slide at least 1 cm away 
from the edged of the slide. Another slide with the smooth end was used as spreader 
and smear was prepared by moving spreader inclined at 30–45° angle to the blood. 
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This Smear was air dried and fixed with Leishman stain and located and observed 
beneath a trinocular research microscope (RXT4, Radical).
2.2 Scanning electron microscopy
To observe the morphological variations in the erythrocyte membrane 
structure in Erythrocytes of patients suffering with hypertension and MI, 
erythrocytes were analyzed by scanning electron microscopy. With this motive 
blood sample was taken in Eppendorf tube containing 10 μl of Heparin (5000 
UI/ml) in 900 μl of pH 7.4 phosphate buffer saline. The blood suspension was 
then centrifuged (1000 rpm for 10 min) and washed with buffer three times. The 
supernatant was removed and replaced by same volume of buffer. One drop of 
these separated erythrocytes were then exposed to 500 μl of 2.5% Glutaraldehyde 
in distilled water overnight at 4°C to fix. Again samples were washed thrice 
with distilled water and centrifuged. About 40 μl of each sample was placed on 
glass covered studs and air dried at room temperature. The Scanning electron 
microscopy (SEM) analysis of prepared samples was accomplished using Jeol, 
Japan (Model—JSM 5610LV).
2.3 Preparation of iso-osmotic dextrose solution
About 5 g of anhydrous Dextrose (Merck) was solubilized in 100 ml of distilled 
water to prepare a 5% w/v iso-osmotic Dextrose solution.
2.4 Preparation of blood sample for zeta potential measurement
About 0.1 ml of blood sample was transferred into 50 ml of freshly prepared 5% 
w/w dextrose solution which is isotonic with the red blood cells [12].
2.5 Zeta potential measurement by zeta meter system 4.0
Zeta meter System 4.0 instrument was used to measure the zeta potential of the 
Erythrocytes [12]. Zeta potential of the system is measured by applying the electric 
field to the samples using electrodes and determining the mobility/velocity of the 
particle under the applied field. Zeta potential was calculated according to the 
simplified Helmholtz-Smoluchowski equation as follows: Mean velocity of the 10 
readings was used to calculate the zeta potential Eq. (1).
  
(1)
where ν = viscosity of sample in poise at temperature “t”; EM = electrophoretic 
mobility; D = dielectric constant.
The electrophoretic cell consists of capillary which is embedded inside a 
chamber having electrodes at both ends having cavity for sample connection 
with electrodes. From the cavity of any one end of the electrophoresis cell 
the Sample is introduced into the capillary to fill it completely. Electrodes 
are connected to the cell with the applied electric field at specific voltage 
of 200 V. Due to the applied electric field charged particles move towards 
oppositely charged electrode. Their velocity under the applied electric field is 
measured and expressed in terms of electro kinetic potential/zeta potential. 
Nowadays, this system is preferably used for determining the zeta potential of 
various types of biological membranes.
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In this method, fresh blood samples were collected from volunteer and 
blood suspension was prepared as described in preparation of sample. Prior 
measurement of zeta potential temperature of and other parameters for ZP 
measurements were adjusted such as light intensity; focal plane and tracking 
duration were optimized for stable data collection with minimal error. The 
collected and prepared samples were then added to the previously cleaned zeta-
meter cell, which were then connected to electrodes and placed under the lens 
over stage. The Erythrocytes were tracked by using remote by microscopically-
acquired video images, values were recorded 10 times for each sample and 
average zeta-potential in mv was obtained standard deviation from software Zeta 
meter-ZM4DAQ software.
2.6 Statistical analysis
The experimental results for ZP are expressed as mean ± standard (SD). 
Investigated groups were compared by the statistical one way analysis of variance 
(ANOVA) and evaluated by Tukey’s multiple comparison tests using Graph Pad 
Prism version 5.00 for Windows. Experimental Results were considered significant 
at p < 0.05 for the different groups which indicates that the control and other 
patient groups differ significantly from one another in all situations.
3. Results and discussion
Morphological study using the smear reveals that there is deformation in RBC 
shape (Anisocytosis) in majority of patients. In Hypertension and patients with 
MI showed RBC deformation from spherical biconcave shape to tear shape which 
further continues to Rouleaux formation (Figure 1a–f). Also, it was observed 
that there is increased aggregation of Erythrocytes in patients suffering from 
Hypertension and Myocardial Infarction compared to normal volunteers.
SEM studies revealed that there are number of deformed erythrocytes observed 
in myocardial infarction patients (Figure 2c) in aggregated form. It was observed 
in patients with hypertension, Erythrocytes appears with uneven surface of cell 
membrane which indicates the oxidative damage in the cell membrane (Figure 2b) 
as compared to normal human erythrocyte as shown in (Figure 2a).
Figure 1. 
(a, b) Erythrocytes of normal human erythrocytes. (c, d) Erythrocytes of patient suffering from Hypertension, 
blood smear showing Rouleaux formation. (e, f) Erythrocytes from patient suffering from myocardial 
infarction, blood smear showing anisocytes.
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Similarly, the result for erythrocyte membrane osmotic fragility in test samples 
reveals that erythrocytes of patients with MI and hypertension become more 
fragile compared to erythrocytes of control group (Figure 3). The erythrocytes are 
very much susceptible to oxidative cellular damage on exposure to the excessive 
oxidative stress.
By using a Zeta meter system 4.0, the zeta potential of human Erythrocytes was 
obtained. The results obtained showed ZP values ranged from −20.13 mV to −26.46 
(+1.87) mV for the healthy individuals with a mean value of −23.39 mV. But the ZP 
values obtained from the Patients with MI is much lower and ranges from −2.58 mV 
to −22.76 (+3.57) mV compared to patients suffering from only Hypertension val-
ues ranges from −12.13 mV to −19.61(+1.20) mV. Also it was observed that Patients 
with MI who underwent CABG and angioplasty and receiving medications the 
zeta potential of such patients was ranging from −21.53 mV to −32.59 mV(+2.95) 
indicating higher stability of erythrocytes in blood vessels (Figure 4).
It was specifically observed that the patients with Hypertension had a mean ZP 
value −16.06 mV and patients with MI mean ZP value was obtained as −9.938 mV 
(p < 0.001). Data obtained from the analysis of blood samples from patients with 
hypertension and healthy volunteers was subjected to one-way ANNOVA with the 
application of Tukey’s multiple comparison tests, and results indicated that there 
is a significant lowering of zeta potential of Patients with Hypertension from that 
Figure 2. 
Scanning electron microscopic images of normal human erythrocytes, patients suffering from hypertension and 
myocardial infarction showing deformed erythrocytes.
Figure 3. 
Comparison between mean erythrocyte fragility of erythrocytes in normal volunteers (CONTROL), patients 
with hypertension and myocardial infarction and myocardial infarction patients on treatment.
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of the healthy volunteers. Also, there is greater decrease in ZP values of patients 
with Hypertension suffering from MI indicate the exacerbation in RBC deformity 
in patients. This may be due to hypertension induced complications. Higher ZP in 
treated patients indicates the increased stability of erythrocytes due to reduced 
oxidative stress.
4. Conclusion
The exact mechanism of development of CVD is complex and is not yet fully 
understood. But from the literature survey it was clear that ROS plays an important 
role in the progression and development of CVD. Also, it was known that there is 
a strong relation between ROS and the pathophysiology of CVD. From the pres-
ent research work it can be concluded that due ROS in Patients with Hypertension 
the erythrocytes are affected, their membrane gets oxidized resulting in various 
types of morphological deformity (Anisocytosis). Also, membrane potential (ZP) 
which is a characteristic property of RBC responsible for free flowing of RBC in the 
blood stream without aggregation, get affected. These conditions get exacerbated 
in erythrocytes of patients suffering from myocardial infarction. Development of 
membrane deformity directly reduces the membrane potential of RBC. Due to oxi-
dation of RBC membrane by ROS, the membrane becomes fragile and therefore the 
fragility of erythrocytes increases in Patients with Hypertension and MI compared 
to healthy volunteers.
Results obtained in our lab suggest that variations in erythrocyte morphology, 
zeta potential, lipid peroxidation and erythrocyte Fragility can act as a key indica-
tor to determine the risk factor of myocardial infarction in hypertensive patients. 
In the present study, we have developed a greater understanding of effect of ROS 
on morphology of RBCs, effect on its membrane potential (ZP) due to deformity 
in the membrane and its erythrocyte fragility. This could be a new way to realize 
a better treatment in hypertensive patients and a prevention of cardiovascular 
complications (i.e.: myocardial infarction, TIA, etc.). However, more works in 
the near future are necessary to improve the detection and treatment of the ROS 
mediated dysfunction.
Figure 4. 
Comparison between mean ZP values of normal volunteers, patients with hypertension and myocardial 
infarction patient and myocardial infarction patients on treatment.
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